76 results match your criteria: "Groupe Hospitalier Cochin Port-Royal[Affiliation]"
[Stress causes premature hair graying in mice through the activation of the sympathetic nervous system].
Med Sci (Paris)
November 2021
Sorbonne Université, UFR 927, BC 60, 4 place Jussieu, 75252 Paris Cedex 05, France.
Reply to: "Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database".
J Hepatol
March 2022
Université de Paris, F-75006 Paris, France; AP-HP.Centre, Groupe Hospitalier Cochin Port Royal, DMU Cancérologie et spécialités médico-chirurgicales, Service d'Hépatologie, Paris, France. Electronic address:
Reply to: "Association of chronic liver disease with the prognosis of COVID-19 patients".
J Hepatol
January 2022
Department of Methodology and Innovation in Prevention, Bordeaux University Hospital, 33000 Bordeaux, France; University of Bordeaux, Inserm UMR 1219-Bordeaux Population Health, 33000 Bordeaux, France.
Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus.
J Hepatol
February 2022
UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, United Kingdom.
Background & Aims: There are uncertainties regarding the burden of liver disease in patients with type 2 diabetes (T2D). Thus, we aimed to quantify the burden of liver disease, identify risk factors, and estimate attributable risks in patients with T2D.
Methods: We measured adjusted hazard ratios of liver disease progression to hepatocellular carcinoma and/or decompensated cirrhosis in a 2010-2020 retrospective, bicentric, longitudinal, cohort of 52,066 hospitalized patients with T2D.
The rise of the hepatitis E virus.
J Hepatol
December 2021
APHP. Université Paris-Saclay, Hôpital Paul Brousse, DMU Biologie - Génétique - PUI, Service de Virologie, Villejuif, France; Institut National de la Santé et de la Recherche Médicale unité 1193, Villejuif, France.
Resection and extemporaneous coverage of a soft tissue sarcoma with a pedicled groin flap in the trochanteric region: Technical note.
Orthop Traumatol Surg Res
June 2022
Service de chirurgie orthopédique et traumatologie, groupe hospitalier Cochin-Port Royal, 27, rue du Faubourg Saint Jacques, 75004 Paris, France.
The main issues pertaining to oncological surgery of the musculoskeletal system are tumour resection with sufficient margins, and the coverage of inherent defects. We report the use of a pedicled cutaneous groin flap as coverage for a trochanteric defect following an oncological resection of a grade III pleomorphic soft tissue sarcoma in a 75-year-old patient. This flap is not routinely used in the coverage of a defect in this region.
View Article and Find Full Text PDFKetamine-induced cholangiopathy in ARDS patients.
Intensive Care Med
October 2021
Department of Anesthesiology and Critical Care and Burn Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier St-Louis-Lariboisière, Paris, France.
Impact of vascular liver disease on the menstrual cycle and metabolic status in premenopausal women.
Clin Res Hepatol Gastroenterol
January 2022
Université de Paris, Department of Gynecological Endocrinology, Hôpitaux Universitaires Centre, AP-HP, Paris, France. Electronic address:
Background: Vascular liver disease (VLD) are rare liver diseases, which affect women at reproductive ages. Main complications are bleeding (portal hypertension, thrombopenia or anticoagulation related) and thromboembolism. Failure of liver function can occur.
View Article and Find Full Text PDFReply to: "Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered".
J Hepatol
October 2021
Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Hepatology Service, Paris, France. Electronic address:
Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.
J Hepatol
October 2021
Université de Paris, AP-HP.Centre, Groupe Hospitalier Cochin Port Royal, DMU Cancérologie et spécialités médico-chirurgicales, Service d'Hépatologie, Paris, France.
Background & Aims: The impact of chronic liver disease on outcomes in patients with COVID-19 is uncertain. Hence, we aimed to explore this association.
Methods: We explored the outcomes of all adult inpatients with COVID-19 in France, in 2020.
[The neuronal protein Arc: a retrotransposon capsid domesticated to serve key synaptic functions].
Med Sci (Paris)
November 2020
Inserm U1016, CNRS UMR8104, Institut Cochin, Groupe hospitalier Cochin-Port-Royal, bâtiment Cassini, 123 boulevard de Port-Royal, 75014 Paris, France.
[The overlooked burden of hepatitis E in hematological patients].
Presse Med
November 2019
Assistance publique-Hôpitaux de Paris (AP-HP), groupe hospitalier Cochin Port Royal, université Paris Descartes, Sorbonne Paris Cité, service hépatologie, institut Pasteur, Inserm, U.1223, 27, rue du faubourg Saint-Jacques, 75014 Paris, France. Electronic address:
[FIB-4 index to rule-out advanced liver fibrosis in NAFLD patients].
Presse Med
December 2019
AP-HP, université Paris Descartes, Sorbonne Paris Cité, groupe hospitalier Cochin Port Royal, service hépatologie, 75014 Paris, France; Institut Pasteur, U.1223, Inserm, 75015 Paris, France.
The FIB-4 index is a biomarker of advanced hepatic fibrosis in a context of fatty liver disease. The calculation of the FIB-4 index requires of age, serum ALT and AST transaminase levels and platelet count. A FIB-4 index<1.
View Article and Find Full Text PDF[Ki67: a surfactant of mitotic chromosomes].
Med Sci (Paris)
October 2019
Sorbonne Université, UFR 927, BC 60, 4 place Jussieu, 75252 Paris Cedex 05, France.
Hepatitis C Virus Infection in Patients With Cancer: Impact on Clinical Trial Enrollment, Selection of Therapy, and Prognosis.
Gastroenterology
October 2019
Université Paris Descartes, Sorbonne Paris Cité and Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalier Cochin Port Royal and Institut Pasteur, Paris, France.
Transmission of Hepatitis E Virus With Plasma Exchange in Kidney Transplant Recipients: A Retrospective Cohort Study.
Transplantation
August 2018
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Background: After observing a case of plasma exchange-mediated hepatitis E virus (HEV) infection in a kidney transplant recipient, we investigated the relationship between plasma exchange and HEV infection after kidney transplantation.
Methods: A cohort of 263 patients who underwent kidney transplantation from January 1, 2011, through December 31, 2012, was screened for HEV markers, including anti-HEV IgG and IgM antibodies and HEV ribonucleic acid (RNA), on 3 consecutive blood samples: 1 before, 1 with a mean (standard deviation) of 9.5 (9) months, and 1 with a mean (standard deviation) of 18.
Erratum to: "How to manage a pregnant woman for emergency care, anesthesia or intensive care? Take home messages from the French Society of Anesthesiology and Intensive Care (SFAR) monothematic one-day meeting" [Anaesth. Crit. Care. Pain. Med. 35 (Suppl 1) (2016) S1-S3].
Anaesth Crit Care Pain Med
June 2018
Department of anaesthesia and surgical intensive care, Gustave-Roussy Cancer Center, 94800 Villejuif, France.
"Who killed JR": Chronic hepatitis C or alcohol use disorders?
J Hepatol
May 2018
Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Institut Pasteur, Institut National de la Santé et de la Recherche Médicale (Inserm), Unité 1223, Paris, France; Hepatology Service, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Cochin Port-Royal, Paris, France.
Alcohol use disorders and associated chronic disease - a national retrospective cohort study from France.
BMC Public Health
July 2017
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, 33 Russell Street, Toronto, ON, M5S 2S1, Canada.
Background: Evidence on diseases caused by or associated with alcohol use disorders (AUDs) has been based on two meta-analyses including rather dated studies. The objective of this contribution was to estimate the risks of all-cause mortality and alcohol-attributable disease categories depending on a diagnosis of AUDs in a national sample for France.
Methods: In a national retrospective cohort study on all inpatient acute and rehabilitation care patients in Metropolitan France 2008-2012 (N = 26,356,361), AUDs and other disease categories were identified from all discharge diagnoses according to standard definitions, and we relied on in-hospital death for mortality (57.
Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin.
AIDS
June 2017
aInstitut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS), INSERM, Sorbonne Universités, Pierre-and-Marie-Curie University bDepartment of Virology, Hôpital Pitié-Salpêtrière cNeurological Intensive Care Unit, Neurology Department, Paris dInfectious and Tropical Diseases Department, Groupe Hospitalier Pitié Salpêtrière, Paris-Sorbonne Universités, Université Pierre et Marie Curie eINSERM, Assistance Publique-Hôpitaux de Paris, Hôpital Paul Brousse, University of Paris-Sud fDepartment of Virology, CHU de Rennes, IRSET-INSERM, Université Rennes, Rennes gInstitut Pasteur, Hepatology Service, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Cochin Port-Royal, Université Paris Descartes, Sorbonne Paris Cité hUMRS CR7, CIMI-Paris, PVI Team, INSERM, Université Pierre et Marie Curie, Sorbonne Universités iPharmaco-Toxicology Department, IAME, Bichat-Claude Bernard Hospital , Université Paris Diderot, Sorbonne Paris Cité jInstitute of Cardiometabolism and Nutrition (ICAN), UMR, Groupe Hospitalier Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Sorbonne Universités kUMR, INSERM, Clamart, Paris, France.
Contribution of alcohol use disorders on the burden of chronic hepatitis C in France, 2008-2013: A nationwide retrospective cohort study.
J Hepatol
September 2017
Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Institut Pasteur, Institut National de la Santé et de la Recherche Médicale (Inserm), Unité 1223, Paris, France; Hepatology Service, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Cochin Port-Royal, Paris, France. Electronic address:
Background & Aims: Hepatitis C virus (HCV) patients are at risk of alcohol use disorders (AUDs). We measured the contribution of AUDs on the burden of chronic HCV infection in French HCV patients.
Methods: The hospital trajectory of 97,347 French HCV patients aged 18-65 in January 2008 were tracked and followed until in-hospital death or December 2013.
Erratum to "Prognosis of patients with chronic hepatitis B in France (2008-2013): A nationwide, observational and hospital-based study".
J Hepatol
May 2017
Translational Health Economics Network (THEN), Paris, France; Infection Antimicrobials Modeling & Evolution (IAME), UMR 1137, Institut National de la Santé et de la Recherche Médicale (INSERM) - Université Paris Diderot, Sorbonne Paris Cité, France.
[The role of BET proteins in γ-retrovirus integration].
Med Sci (Paris)
December 2016
ER6, Université Pierre et Marie Curie, 4, place Jussieu, 75005 Paris, France.
Prognosis of patients with chronic hepatitis B in France (2008-2013): A nationwide, observational and hospital-based study.
J Hepatol
March 2017
Translational Health Economics Network (THEN), Paris, France; Infection Antimicrobials Modeling & Evolution (IAME), UMR 1137, Institut National de la Santé et de la Recherche Médicale (INSERM) - Université Paris Diderot, Sorbonne Paris Cité, France.
Background & Aims: How risk factors associated with chronic hepatitis B (CHB) modify liver disease progression and mortality has been scarcely reported outside of Asia. We aimed to evaluate these risk factors in a French population between 2008 and 2013.
Methods: All individuals discharged with CHB from acute and post-acute care hospitals in Metropolitan France between January 2008 and December 2013 were selected.
[A murine model for an ignored chronic infection: hepatitis E !].
Med Sci (Paris)
October 2016
Université Paris Descartes, assistance publique-hôpitaux de Paris, groupe hospitalier Cochin Port Royal, service d'hépatologie, Inserm U1223, Institut Pasteur, Paris, France.